SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Magainin Pharm (MAGN)
MAGN 8.625-2.1%9:43 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kech who wrote (136)4/26/1998 4:04:00 PM
From: kech  Read Replies (2) of 233
 
Shep - When you go to hear Zasloff can you ask him these questions? I heard Wall Street Week this Friday and they talked about BioTech stocks. They mentioned a product from Pfizer called Retrovan (I think that was it) that was an antibiotic that worked more effectively than the altertantive if 14 out 14 uses it had been tested in. Is there any threat here for Magainin's antibiotic.
Also they Mentioned Merck's 1 pill a day, non-steroidal treatment for Asthma called Singulair. Any pre-emption here for Magainin's plans for Asthma research? Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext